Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism

原发性醛固酮增多症 医学 肾上腺切除术 醛固酮 泌尿科 低钾血症 内科学
作者
Takuyuki Katabami,Hisashi Fukuda,Hisaichiro Tsukiyama,Yasushi Tanaka,Yoshiyu Takeda,Isao Kurihara,Hiroshi Ito,Mika Tsuiki,Takamasa Ichijo,Norio Wada,Yuki Shibayama,Takanobu Yoshimoto,Yoshihiro Ogawa,Junji Kawashima,Masakatsu Sone,Nobuya Inagaki,K. Takahashi,Megumi Fujita,Minemori Watanabe,Yuichi Matsuda,Hiroki Kobayashi,Hirotaka Shibata,Kohei Kamemura,Michio Otsuki,Yukihiko Fujii,Kōichi Yamamoto,Atsushi Ogo,Toshihiko Yanase,Tomoko Suzuki,Mitsuhide Naruse
出处
期刊:Journal of Hypertension [Lippincott Williams & Wilkins]
卷期号:37 (7): 1513-1520 被引量:44
标识
DOI:10.1097/hjh.0000000000002070
摘要

Objectives: Current clinical guidelines of primary aldosteronism recommend adrenalectomy (AdX) for unilateral primary aldosteronism based on the studies showing the potential superiority of AdX over the medical treatment. However, since most medically treated cases consisted of bilateral primary aldosteronism and all surgically treated cases consisted of unilateral primary aldosteronism, the different subtype of primary aldosteronism could be a bias for their effects. This study compared the effects of AdX and medical therapy in patients with unilateral primary aldosteronism confirmed by adrenal vein sampling. Methods: Of the 339 patients with unilateral primary aldosteronism in the Japan Primary Pldosteronism Study data base, unilateral AdX and treatment with mineral corticoid receptor antagonists (MRAs) was done in 276 patients (AdX group) and in 63 patients (MRAs group), respectively. The effects were compared by the clinical (improvement of blood pressure) and biochemical outcomes (improvement of hypokalemia). Results: At baseline, use of potassium replacement, plasma aldosterone concentration, aldosterone-to-renin ratio, estimated glomerular filtration rate, and prevalence of adrenal mass on imaging were higher in the AdX group than in the MRAs group. At 6 months after commencement of specific treatment for primary aldosteronism, clinical outcome and biochemical outcome in the AdX group were superior than those in the MRAs group. The difference of the outcome between the two groups were the case even after adjusting for the different clinical backgrounds in the two groups before the specific treatment. Conclusion: Our study provides evidence that AdX is the first choice of treatment in the patients with unilateral primary aldosteronism in terms of clinical and biochemical outcome.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xt_489完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
YX发布了新的文献求助10
2秒前
土豆··发布了新的文献求助10
3秒前
鳗鱼曼岚发布了新的文献求助10
4秒前
LIN发布了新的文献求助10
4秒前
5秒前
YUMI发布了新的文献求助10
6秒前
6秒前
孙帅完成签到,获得积分10
6秒前
6秒前
lgw完成签到,获得积分20
6秒前
刘老哥6完成签到,获得积分10
6秒前
徐以鑫发布了新的文献求助30
6秒前
李爱国应助aa采纳,获得50
7秒前
Jaychai发布了新的文献求助10
7秒前
张雷应助易海之旅采纳,获得10
8秒前
123发布了新的文献求助10
8秒前
量子星尘发布了新的文献求助10
9秒前
静默完成签到 ,获得积分10
9秒前
bkagyin应助这两天天气咋样采纳,获得10
9秒前
狂野忆文发布了新的文献求助10
10秒前
善学以致用应助望北楼主采纳,获得10
10秒前
naiyouqiu1989完成签到,获得积分10
10秒前
12秒前
希望天下0贩的0应助haoyooo采纳,获得10
12秒前
13秒前
蝉时雨完成签到,获得积分10
13秒前
sunishope完成签到 ,获得积分10
13秒前
14秒前
传奇3应助羊丢丢啊丢丢采纳,获得10
14秒前
18275412695发布了新的文献求助10
14秒前
易海之旅完成签到,获得积分10
14秒前
zzzzzzzp应助wnx001111采纳,获得10
15秒前
pluto应助王家腾采纳,获得10
15秒前
Jasper应助唐哈哈采纳,获得10
15秒前
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance 500
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970120
求助须知:如何正确求助?哪些是违规求助? 3514810
关于积分的说明 11176124
捐赠科研通 3250136
什么是DOI,文献DOI怎么找? 1795198
邀请新用户注册赠送积分活动 875647
科研通“疑难数据库(出版商)”最低求助积分说明 804964